WILMINGTON, DE, Truveris, the leader in pharmacy cost containment and program performance, today announced it has raised $15 million in Series E investment.			
			 Truveris today announced it has raised $15 million in Series E investment led by two lead investors, Canaan Partners and New Leaf Venture Partners.
Truveris is a leading healthcare technology company focused on transforming and reducing pharmacy spend. Truveris has built the only independent, data-led, tech platform that creates complete PBM pricing transparency and drives competition to reduce costs for employers. Our solutions replace traditional pharmacy procurement and renewal models for self-insured employers by providing deep insights, comparative procurement, 100% claims analysis, and member engagement solutions.
				  
				  (c) by Massinvestor, Inc.  For contact info, please check out our 
about page.